We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

3 hedge funds and large institutions have $2.3M invested in Aethlon Medical in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $2.12M → $2.3M (+$184K)

0% more funds holding

Funds holding: 3 → 3 (0)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TDC
Thompson Davis & Co
Virginia
-$16K
2
AIG
American International Group
New York
-$5K
3
TRCT
Tower Research Capital (TRC)
New York
-$5K

AEMD Hedge Fund Activity: Q2 2016 in Review

3 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2016, worth a combined $2.3M — up 8.7% from $2.12M a quarter earlier.

Fund positioning in AEMD was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Thompson Davis & Co, cutting an estimated $16K.

  • 3 institutional investors held Aethlon Medical (AEMD) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $2.3M of Aethlon Medical stock for Q2 2016, up 8.7% quarter-over-quarter.
  • 0 funds opened new Aethlon Medical positions in Q2 2016 and 0 closed out.
  • The largest Aethlon Medical seller in Q2 2016 was Thompson Davis & Co, an estimated $16K sold.

Based on aggregated 13F filings for Q2 2016.